CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.
Skowera A, Ellis RJ, Varela-Calviño R, Arif S, Huang GC, Van-Krinks C, Zaremba A, Rackham C, Allen JS, Tree TI, Zhao M, Dayan CM, Sewell AK, Unger WW, Drijfhout JW, Ossendorp F, Roep BO, Peakman M.
Skowera A, et al.
J Clin Invest. 2008 Oct;118(10):3390-402. doi: 10.1172/JCI35449.
J Clin Invest. 2008.
PMID: 18802479
Free PMC article.